Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
Simon B. Goldberg, Benjamin Shechet, Christopher R. Nicholas, et al.
Psychological Medicine (2020) Vol. 50, Iss. 16, pp. 2655-2666
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder
Michael P. Bogenschutz, Stephen Ross, Snehal Bhatt, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 10, pp. 953-953
Open Access | Times Cited: 422
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis
Sipan Haikazian, David Chen‐Li, Danica E. Johnson, et al.
Psychiatry Research (2023) Vol. 329, pp. 115531-115531
Closed Access | Times Cited: 46
Sustained effects of single doses of classical psychedelics in humans
Gitte M. Knudsen
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 145-150
Open Access | Times Cited: 39
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
Ricarda Evens, Marianna E. Schmidt, Tomislav Majić, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 26
Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Daniela-Mădălina Ciucă Anghel, Gabriela Viorela Nițescu, Andreea Taisia Tiron, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4969-4969
Open Access | Times Cited: 26
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study
Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 215-234
Open Access | Times Cited: 9
What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes
Elias C. Acevedo, Scott Uhler, Kaitlyn P. White, et al.
Journal of Psychoactive Drugs (2024), pp. 1-10
Closed Access | Times Cited: 8
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Psychedelics, Sociality, and Human Evolution
José Manuel Rodríguez Arce, Michael Winkelman
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 49
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States
Otto Simonsson, Simon B. Goldberg
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 11-18
Open Access | Times Cited: 33
Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users
Baptiste Fauvel, Samuli Kangaslampi, Lana Strika-Bruneau, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 2, pp. 170-179
Closed Access | Times Cited: 29
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 649-659
Open Access | Times Cited: 22
Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
Chia‐Ling Yu, Chih‐Sung Liang, Fu‐Chi Yang, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 938-938
Open Access | Times Cited: 25
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality
Ivana Solaja, Kate Haldane, Natasha L. Mason, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105570-105570
Closed Access | Times Cited: 5
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
Giordano Novak Rossi, Jaime E. C. Hallak, José Carlos Bouso, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 761-776
Closed Access | Times Cited: 20
Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study
Lucas F. Borkel, Jaime Rojas-Hernández, Luis Alberto Henríquez‐Hernández, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 2, pp. 165-176
Closed Access | Times Cited: 12
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 4
Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
Marianne Destoop, Pavel Mohr, Florence Butlen-Ducuing, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access
Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors
Zishan Jiwani, Simon B. Goldberg, Jack Stroud, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0310160-e0310160
Open Access
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
Tomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Journal of Psychopharmacology (2025)
Closed Access
Ketamine-Occasioned Mystical Experience in Veterans with Treatment-Resistant Depression: A Retrospective Exploratory Analysis
Kush V. Bhatt, Jason Compton, Em Ellerman, et al.
Psychedelic Medicine (2025)
Closed Access
Validation of a new instrument for assessing attitudes on psychedelics in the general population
Marija Franka Žuljević, Ivan Buljan, Mia Leskur, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective
Daniel Meling, Milan Scheidegger
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 10
Stutterers’ experiences on classic psychedelics: A preliminary self-report study
Eric S. Jackson, Noam Goldway, Hope Gerlach, et al.
Journal of Fluency Disorders (2024) Vol. 81, pp. 106062-106062
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top